Allogene Therapeutics, Inc. SEC filings ALLO
Allogene Therapeutics, Inc. has 585 filings in SEC EDGAR's recent list, going back to Apr 19, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations
|
May 13, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
Apr 15, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Other events
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 25, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K | Current report | Oct 7, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Material agreement
|
May 31, 2024 | May 24, 2024 |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Restatement
|
Feb 16, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 31, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Other events
|
Jan 5, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Other events
|
Dec 19, 2023 | Dec 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 14, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Other events
|
Jun 7, 2023 | Jun 3, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 20, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2023 | Dec 27, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Other events
|
Oct 6, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Other events
|
Sep 21, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 15, 2021 | Dec 10, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Other events
|
Oct 7, 2021 | Oct 7, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Officer or director change
|
May 20, 2021 | May 18, 2021 |
| 8-K |
Current report
Other events
|
May 19, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 15, 2020 | Dec 14, 2020 |
| 8-K |
Current report
Other events
|
Dec 7, 2020 | Dec 5, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2020 | Nov 4, 2020 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 26, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Other events
|
Jun 4, 2020 | Jun 1, 2020 |
| 8-K |
Current report
Other events
|
May 29, 2020 | May 29, 2020 |
| 8-K |
Current report
Results of operations
|
May 6, 2020 | May 6, 2020 |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 27, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2020 | Feb 27, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Material agreement
|
Nov 5, 2019 | Nov 5, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2019 | Jun 6, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Other events
|
Apr 10, 2019 | Apr 10, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2019 | Mar 8, 2019 |
| 8-K |
Current report
Material agreement
|
Feb 20, 2019 | Feb 19, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2018 | Dec 10, 2018 |
| 8-K |
Current report
Material agreement
|
Oct 29, 2018 | Oct 25, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 15, 2018 | Oct 15, 2018 |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALLO (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1737287
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.